Author | Benjamin Maughan, MD, PharmD | OncLive

Author | Benjamin Maughan, MD, PharmD

Articles

Dr. Maughan on Enzalutamide Plus Radium-223 in mCRPC

July 04, 2018

Video

Benjamin Maughan, MD, PharmD, instructor, Division of Medical Oncology, Huntsman Cancer Institute, discusses enzalutamide (Xtandi) plus radium-223 (Xofigo) in metastatic castration-resistant prostate cancer.

x